Induction ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsCisplatinCombined Modality TherapyRemission InductionChemotherapy, AdjuvantTreatment OutcomeDisease-Free SurvivalCyclophosphamideNeoadjuvant TherapyEtoposideSurvival AnalysisCytarabineHead and Neck NeoplasmsAntineoplastic AgentsDoxorubicinSurvival RateNeoplasm StagingLeukemia, Myeloid, AcuteTaxoidsDaunorubicinCarcinoma, Squamous CellCarboplatinLung NeoplasmsPaclitaxelPrognosisFluorouracilDrug Administration ScheduleIfosfamideVincristineEnzyme InductionRadiotherapy, AdjuvantCarcinoma, Non-Small-Cell LungPrecursor Cell Lymphoblastic Leukemia-LymphomaChemoradiotherapyMethotrexateIdarubicinVinblastineLaryngectomyHypopharyngeal NeoplasmsRadiotherapyBleomycinLeukemia, MyeloidNeoplasm Recurrence, LocalRadiotherapy DosageTransplantation, AutologousDeoxycytidineBreast NeoplasmsSalvage TherapyNasopharyngeal NeoplasmsFollow-Up StudiesKaplan-Meier EstimateNeutropeniaTime FactorsMelphalanGranulocyte Colony-Stimulating FactorAntimetabolites, AntineoplasticTesticular NeoplasmsLaryngeal NeoplasmsAsparaginaseProspective StudiesMucositisOrgan Sparing TreatmentsMitoxantroneLevoleucovorinVindesineCranial IrradiationDose FractionationHematopoietic Stem Cell TransplantationDose-Response Relationship, DrugGlossectomyRadiotherapy, High-EnergyDrug Resistance, NeoplasmOrganoplatinum CompoundsConsolidation ChemotherapyNeoplasm MetastasisThiotepaMesnaNeoplasms, Germ Cell and EmbryonalAnthracyclinesNeoplasm, ResidualAcute DiseaseGerminomaRecurrenceOropharyngeal NeoplasmsBone MarrowBridged CompoundsAdenocarcinomaLeukopeniaCamptothecinThioguanineLeucovorinFeasibility StudiesLymphoma, Non-HodgkinLymphatic MetastasisAntineoplastic Agents, PhytogenicClinical Trials as TopicGranulocyte Precursor CellsPneumonectomyAntibiotics, Antineoplastic